Agouron Stock Soars in Trading: The value...
- Share via
Agouron Stock Soars in Trading: The value of La Jolla-based Agouron Pharmaceuticals’ stock more than doubled during heavy trading Friday after the company reported success in finding the 3-D structure of a key enzyme in the AIDS virus. Sensing a possible AIDS breakthrough, investors rushed to buy Agouron, sending the stock to an all-time high of $19 per share in NASDAQ over-the-counter trading, up from $9 at the start. Six months ago, Agouron was trading at its all-time low of $3.25. Just as impressive was Friday’s volume: 604,200 shares, more than 100 times Agouron’s normal trading level.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.